CN1146359A - Feijiwan pill (for lung disease) and preparation method - Google Patents

Feijiwan pill (for lung disease) and preparation method Download PDF

Info

Publication number
CN1146359A
CN1146359A CN96117648A CN96117648A CN1146359A CN 1146359 A CN1146359 A CN 1146359A CN 96117648 A CN96117648 A CN 96117648A CN 96117648 A CN96117648 A CN 96117648A CN 1146359 A CN1146359 A CN 1146359A
Authority
CN
China
Prior art keywords
radix
pill
weight
fried
mel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN96117648A
Other languages
Chinese (zh)
Other versions
CN1068209C (en
Inventor
唐令海
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN96117648A priority Critical patent/CN1068209C/en
Publication of CN1146359A publication Critical patent/CN1146359A/en
Application granted granted Critical
Publication of CN1068209C publication Critical patent/CN1068209C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a kind of medicine for pulmonary tuberculosis, which is composed of moderate degree stir-baked lucid aspara gus etc. moderate degree stir-baked slow fire baked or air dried lily etc. 6 medicines and tuber of pinellia prepared by conventional method. The compatibility of the above mentioned medicines is proceeded in accordance with the weight percentage proportion then they are crushed into powder and mixed with the refined honey and steamed smelted donkey-hide gelatin to make into pills. It has certain curative effect for tuberculous pleurisy, hemoptysis, tracheitis, infantile pigeon breast, and debilitating due to deficiency syndrome of lung.

Description

Feijiwan pill (for lung disease) and manufacture method thereof
The present invention relates to a kind of phthisical medicine Feijiwan pill (for lung disease) and manufacture method thereof of curing mainly, is to be mixed with pill with the Chinese crude drug compatibility and with Mel.This pill also has a certain curative effect to tuberculous pleuritis, tracheitis, cough haematemesis, children's's pigeon chest, the deficiency of the lung are weak etc.
At present, have with treatment by Chinese herbs is phthisical " spirit of bringing back to life ", become the cream external treatment, effect is not as treatment by oral administration of medicines, and " ointment for eliminating tuberculosis " consumption is big, and one day consumption is specially controlled each paratuberculous " Yuheshukangping-medicine for treatment of tuberculosis " more than 50 grams, the cost height, and expenses for medicine was up to 300-500 unit in every month.When generally using treatment by Chinese herbs at present, think that pulmonary tuberculosis is that the deficiency of YIN should be mended more, use Radix Ginseng, the Radix Astragali, Cordyceps, Radix Rehmanniae Preparata, Radix Angelicae Sinensis, Fructus Schisandrae Chinensis isothermal medicine more, dry lung, real that it is anti-.And the normal health medicine that lacks prevention, the lung tissue that keeps healthy, takes into account kidney,liver,spleen, stomach, intestinal, the heart in the medicine, curative effect is not very good.
The objective of the invention is to: invent a kind of with low cost, treatment convenient be suitable for cure mainly phthisical Chinese medicine medicine Feijiwan pill (for lung disease) and manufacture method thereof.
The present invention realizes its purpose like this: this pill system is with Chinese crude drug compatibility and formulated with Mel, and the percentage by weight of its medical material component (%) is:
Radix Asparagi 1-6, sharp shellfish 2-10, Radix Ophiopogonis 2-10, Colla Corii Asini 1-6, Bulbus Fritillariae Thunbergii 1-8, Thallus Laminariae (Thallus Eckloniae) 5-10, capital summer 1-6, Radix Glehniae 1-5, Poria 5-15, Semen Coicis 5-15, Pseudobulbus Bletillae (Rhizoma Bletillae) 20-60, Radix Stemonae 5-15, Bulbus Lilii 5-15, total amount is 100%, Mel weight is 100 ± 5% of medical material component gross weight.
The manufacture method of this pill is: at first with the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Ophiopogonis, Radix Asparagi, the Radix Stemonae, Thallus Laminariae (Thallus Eckloniae) 80 ℃ to 120 ℃ parches of moderate heat, the Pseudobulbus Bletillae (Rhizoma Bletillae) was fried 1 to 2 hour, Radix Asparagi, Radix Ophiopogonis was fried 0.5 to 1 hour, the Radix Stemonae was fried 20 minutes to 1 hour, Thallus Laminariae (Thallus Eckloniae) was fried 20 minutes to 40 minutes, then with Semen Coicis, Bulbus Lilii, Poria, Bulbus Fritillariae Thunbergii, Radix Glehniae, the point shellfish descends or dries for 50 ℃ to 70 ℃ to dewater at low baking temperature, then with treated medical material and capital summer of making by the Rhizoma Pinelliae, measure by weight percentage, be ground into powder, by the dosage furnacing honey, evaporate Colla Corii Asini at last, make pill with the medicinal powder mix homogeneously.
Further specify below in conjunction with embodiment, but be not limited only to this.
Example one
1, pill component compatibility and percentage by weight thereof (%):
Radix Asparagi 1, sharp shellfish 2, Radix Ophiopogonis 2, Colla Corii Asini 1, Bulbus Fritillariae Thunbergii 2, Thallus Laminariae (Thallus Eckloniae) 5, the capital summer 1, Radix Glehniae 1, Poria 5, Semen Coicis 5, the Radix Stemonae 5, the Pseudobulbus Bletillae (Rhizoma Bletillae) 60, Bulbus Lilii 10, total amount is 100%, Mel weight is 100 ± 5% of Chinese crude drug component gross weight.
2, make the method for pill.
At first with the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Ophiopogonis, Radix Asparagi, the Radix Stemonae, the Thallus Laminariae (Thallus Eckloniae) moderate heat parch appropriateness with 80 ℃ to 120 ℃, the Pseudobulbus Bletillae (Rhizoma Bletillae) was fried 1 to 2 hour, and Radix Ophiopogonis, Radix Asparagi are fried half an hour to 1 hour, and the Radix Stemonae was fried 20 minutes to 1 hour, and Thallus Laminariae (Thallus Eckloniae) was fried 20 minutes to 40 minutes.Again with Semen Coicis, Bulbus Lilii, Poria, Bulbus Fritillariae Thunbergii, sharp shellfish, Radix Glehniae with 50 ℃ to 70 ℃ low baking temperature or dry and dewater.With treated medical material and capital summer of being made according to a conventional method by the Rhizoma Pinelliae, with its percentage by weight metering, be ground into powder then, the Mel of last refinery dosage evaporates Colla Corii Asini, and with the medicinal powder mixing and stirring, make pill and get final product.
3, medicine is supervised detection by Kaijiang County, Sichuan Province medicine inspecting institute.
Note, avoid when 4, treatment is used and the keeping requirement.
Instructions about how to take medicine: every day 2-4 time, day dose 25-35 gram is measured the 7-9 gram at every turn.Service once in 8 of breakfast, lunch and dinner ante cibum every day and evenings, take with the Flos Plumeriae Acutifoliae boiled water before the morning of every day, the supper, all the other times take with boiled water.Also can directly the pill fragmentation be swallowed.Avoid clothes during flu, or the clothes that reduce by half, take with boiled water.
Taboo: forbid sexual life in the treatment phase; Dry property foods such as fasting wine, cock, Cyprinus carpio, Fructus Piperis, hot pepper, Rhizoma Zingiberis Recens; Diet goose, sow, beef or mutton, white sugar and brown sugar; Edible crystal sugar and honey sugar; Take a good rest, avoid too tired.
Keeping: pill is deposited in the vial, places dry shady and cool place.
5, clinical trial and effect
Reach hospital and township hospital's therapeutic test in 2 cities, 5 counties, valley district in Sichuan Province, to 80 routine pulmonary tuberculosis patients, cure rate is more than 90%, effective percentage 100%.Generally looking state of an illness treatment can cure in 2-10 month.Through investigation, this medicine is taken for a long time and is not found any toxic and side effects liver,kidney,spleen, stomach, intestinal, the heart etc. are all had certain benefit, has the effect of strong lung tissue, has prevention, health care, treatment function.
Example two
1, pill component compatibility and percentage by weight thereof (%) are:
Radix Asparagi 3, sharp shellfish 4, Radix Ophiopogonis 5, Colla Corii Asini 3, Bulbus Fritillariae Thunbergii 4, Thallus Laminariae (Thallus Eckloniae) 8, capital summer 3, Radix Glehniae 3, Poria 15, Semen Coicis 12, the Pseudobulbus Bletillae (Rhizoma Bletillae) 20, the Radix Stemonae 15, Bulbus Lilii 5.Total amount is 100%.Mel weight is 100 ± 5% of Chinese crude drug gross weight.
2, the pill manufacture method, supervise that detection, treatment are noted, taboo and keeping require all with embodiment one.
3, clinical trial and effect.
Test hospital is with example one.To 100 routine tuberculosis treatments, cure rate 89%, effective percentage 99%, invalid 1%.All the other effects are with example one.
Example three
1, pill component compatibility and percentage by weight (%) are:
Radix Asparagi 3, sharp shellfish 10, Radix Ophiopogonis 10, Colla Corii Asini 6, Bulbus Fritillariae Thunbergii 1, Thallus Laminariae (Thallus Eckloniae) 10, the capital summer 6, Radix Glehniae 3, Poria 5, Semen Coicis 5, the Pseudobulbus Bletillae (Rhizoma Bletillae) 20, the Radix Stemonae 6, Bulbus Lilii 15, total amount is 100%, Mel weight is 100 ± 5% of Chinese crude drug component gross weight.
2, the pill manufacture method, supervise that detection, treatment are noted, taboo and keeping require with example one.
3, clinical trial and effect
Warp is in example one described hospital, to 50 routine pulmonary tuberculosis human therapies, cure rate 88%, effective percentage 98%, invalid 2%.In this example, capital summer dosage is higher, but Radix Asparagi, Radix Ophiopogonis compatibility are arranged, so also do not produce any toxic side effects, all the other effects are with example one.
Example four
1, pill component compatibility and percentage by weight (%).
Radix Asparagi 4, sharp shellfish 2, Radix Ophiopogonis 3, Colla Corii Asini 3, Bulbus Fritillariae Thunbergii 8, Thallus Laminariae (Thallus Eckloniae) 5, the capital summer 3, Radix Glehniae 5, Poria 8, Semen Coicis 15, the Pseudobulbus Bletillae (Rhizoma Bletillae) 30, the Radix Stemonae 9, Bulbus Lilii 5, total amount is 100%.Mel weight is 100 ± 5% of medical material gross weight.
2, the pill manufacture method, supervise that detection, treatment are noted, taboo, keeping require all with example together.
3, clinical trial and effect
Test hospital is with example one, to 100 pulmonary tuberculosis human therapies.Cure rate is 89%, and effective percentage is 100%.All the other effects are with example one.
Example five
1, pill component and percentage by weight thereof (%)
Radix Asparagi 6, sharp shellfish 5, Radix Ophiopogonis 4, Colla Corii Asini 2, Bulbus Fritillariae Thunbergii 3, Thallus Laminariae (Thallus Eckloniae) 6, the capital summer 2, Radix Glehniae 2, Poria 7, Semen Coicis 5, the Pseudobulbus Bletillae (Rhizoma Bletillae) 46, the Radix Stemonae 5, Bulbus Lilii 7, total amount is 100%.Mel weight is 100 ± 5% of medical material gross weight.
2, the pill manufacture method, supervise and detect, use attention, taboo, keeping require all with example together.
3, clinical trial and effect
In the hospital of example one to 80 routine tuberculosis treatments, cure rate 90%, effective percentage 100%.All the other effects are with example one.
Pharmacology and effect analysis.This pill is made by proportioning and method by above-mentioned Chinese crude drug, overcome the compatibility that conventional Chinese medicine should be mended with YIN nourishing merely, except that using the phthisical medicine Pseudobulbus Bletillae (Rhizoma Bletillae) of treatment, the Radix Stemonae, Bulbus Lilii, Radix Glehniae, also be furnished with the lung tissue of perfecting, take into account kidney,liver,spleen, stomach, intestinal, the heart, germ-resistant medicine, and be aided with egg, nutrient substance such as Mel make lung strong, and the lung disease disappears thereupon.Therefore, this Feijiwan pill (for lung disease) has strengthening vital QI to eliminate pathogenic factors, recovery, strong lung tissue and physiological function, YIN nourishing is supported lung, soft sharp eliminating stagnation blood stasis dispelling, granulation promoting bacterium for killing insect, cough-relieving, clearing away lung-heat and have prevention, health care, treatment one effect, reach treating both the principal and secondary aspects of a disease, the effect that different disease is ruled together, also weak to pulmonary tuberculosis tuberculous pleurisy, cough haematemesis, tracheitis, children's's pigeon chest, the deficiency of the lung, pain in the lung etc. has certain curative effect.This pill removes the capital summer (being made according to a conventional method by the Rhizoma Pinelliae), small toxicity, warm in nature outside, other be nontoxic, property flat or tremble with fear, sweet, therefore, any toxic and side effects is not found in clinical trial.So this pill has unique curative effect to pulmonary tuberculosis, general effective percentage reaches more than 98%, and cure rate is more than 88%.Get with above-mentioned medical material, inexpensive, thereby economic and practical.

Claims (2)

1, a kind ofly curing mainly phthisical medicine Feijiwan pill (for lung disease), is with Chinese crude drug compatibility and the pill formulated with Mel, and it is characterized in that: various medical material components and percentage by weight (%) thereof are:
Radix Asparagi 1-6, sharp shellfish 2-10, Radix Ophiopogonis 2-10, Colla Corii Asini 1-6,
Bulbus Fritillariae Thunbergii 1-8, Thallus Laminariae (Thallus Eckloniae) 5-10, capital summer 1-6, Radix Glehniae 1-5,
Poria 5-15, Semen Coicis 5-15, Pseudobulbus Bletillae (Rhizoma Bletillae) 20-50, Radix Stemonae 5-15,
Bulbus Lilii 5-15, total amount is 100%, Mel weight is 100 ± 5% of medical material component gross weight.
2, the manufacture method of Feijiwan pill (for lung disease) according to claim 1, it is characterized in that: at first with the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Ophiopogonis, Radix Asparagi, the Radix Stemonae, Thallus Laminariae (Thallus Eckloniae) is with 80 ℃ to 120 ℃ moderate heat parch, the Pseudobulbus Bletillae (Rhizoma Bletillae) was fried 1 to 2 hour, Radix Asparagi, Radix Ophiopogonis was fried 0.5 to 1 hour, the Radix Stemonae was fried 20 minutes to 1 hour, Thallus Laminariae (Thallus Eckloniae) was fried 20 minutes to 40 minutes, again with Semen Coicis, Bulbus Lilii, Poria, Bulbus Fritillariae Thunbergii, Radix Glehniae, the point shellfish is under 50 ℃ to 70 ℃ low baking temperature or dry and dewater, then with treated Chinese crude drug and capital summer of making by the Rhizoma Pinelliae, by the metering of its percentage by weight, be ground into powder, at last with the Mel refinery of dosage, Colla Corii Asini evaporates, and makes pill with the Chinese drugs powder mix homogeneously.
CN96117648A 1996-07-30 1996-07-30 Feijiwan pill (for lung disease) and preparation method Expired - Fee Related CN1068209C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN96117648A CN1068209C (en) 1996-07-30 1996-07-30 Feijiwan pill (for lung disease) and preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN96117648A CN1068209C (en) 1996-07-30 1996-07-30 Feijiwan pill (for lung disease) and preparation method

Publications (2)

Publication Number Publication Date
CN1146359A true CN1146359A (en) 1997-04-02
CN1068209C CN1068209C (en) 2001-07-11

Family

ID=5124481

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96117648A Expired - Fee Related CN1068209C (en) 1996-07-30 1996-07-30 Feijiwan pill (for lung disease) and preparation method

Country Status (1)

Country Link
CN (1) CN1068209C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101313986B (en) * 2008-06-06 2011-10-26 叶志军 Orally taken traditional Chinese medicine for treating cough caused by dryness-heat
CN102600280A (en) * 2012-03-26 2012-07-25 许凤霞 Traditional Chinese medical composition for treatment of pediatric cough
CN103285296A (en) * 2013-06-28 2013-09-11 刘克志 Traditional Chinese medicine for treating phthisis
CN105250849A (en) * 2015-11-20 2016-01-20 文永忠 Chuangen Duanmi pills

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1051002C (en) * 1993-09-10 2000-04-05 顾春生 Chinese medicinal herbs composition for treating tuberculosis of lung with cavitation

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101313986B (en) * 2008-06-06 2011-10-26 叶志军 Orally taken traditional Chinese medicine for treating cough caused by dryness-heat
CN102600280A (en) * 2012-03-26 2012-07-25 许凤霞 Traditional Chinese medical composition for treatment of pediatric cough
CN103285296A (en) * 2013-06-28 2013-09-11 刘克志 Traditional Chinese medicine for treating phthisis
CN105250849A (en) * 2015-11-20 2016-01-20 文永忠 Chuangen Duanmi pills

Also Published As

Publication number Publication date
CN1068209C (en) 2001-07-11

Similar Documents

Publication Publication Date Title
CN1201668C (en) Healthy cold tea and producing method thereof
CN100998843A (en) Medicinal composition for treating cholecystitis
AU749922B2 (en) A medicament for treating recurrent ulcer of mouth and Behcet's syndrome
CN103638190B (en) The Chinese medicine for the treatment of acute cholecystitis
CN1068209C (en) Feijiwan pill (for lung disease) and preparation method
CN1054528C (en) Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin"
CN102526639B (en) Chinese medicinal composition for treating hyperlipidemia and preparation method thereof
CN102657795A (en) Traditional Chinese medicine preparation for promoting postoperative incision healing
CN102145127A (en) Medicament for treating rheumatoid arthritis and preparation method thereof
CN103444957A (en) Health tea electuary for treating constipation based on food therapy
CN100335119C (en) Chinese medicinal composition for treating enteritis
CN103599455A (en) Traditional Chinese medicine capsule for removing freckle
CN1594536A (en) Chinese herbal medicine wine and its preparing method
CN102218131B (en) External Chinese herbal medicine composition for promoting tissue regeneration and knitting bones
CN105770436A (en) Ointment for burns and scalds
CN102293974B (en) Chinese medicinal composition for treating osseous tuberculosis, and preparation method thereof
CN1191086C (en) Medicine for treating cold in summer and autumn
CN1618439A (en) Broad-specturm medicine for treating snake venom poisoning
CN1057680C (en) Traditional Chinese medicine for curing dysentery
CN102389545A (en) Traditional Chinese medicine for treating diabetic gout
CN102631496B (en) Traditional Chinese medicine composition capable of improving immunity and resisting fatigue
CN106361984A (en) Nine-raw-material blood stanching powder and preparing method and application thereof
CN101224295A (en) Chinese traditional medicine compounds for treating digestive system tumor and preparing method thereof
CN1107066A (en) Healthful capsule making method
CN1927349A (en) Traditional Chinese medicine for treating rheumatism and its preparing process

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee